Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 18,00
Quantità: 1 disponibili
Aggiungi al carrello78 figs. in 105 sep. illus., 60 tabs., XIII, 325 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Medical Radiology. Radiation Oncology. Sprache: Englisch.
Da: Phatpocket Limited, Waltham Abbey, HERTS, Regno Unito
EUR 39,54
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Buchpark, Trebbin, Germania
EUR 16,11
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 325 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 354.
Da: Majestic Books, Hounslow, Regno Unito
EUR 139,67
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 354.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 142,21
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. 354.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. xiii + 325.
Da: Majestic Books, Hounslow, Regno Unito
EUR 167,83
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. xiii + 325 78 Illus. (54 Col.).
Condizione: New. pp. xvi + 344.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,39
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,39
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: preigu, Osnabrück, Germania
EUR 104,15
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Radiation Oncology Advances | Søren M. Bentzen (u. a.) | Taschenbuch | xvi | Englisch | 2010 | Springer | EAN 9781441942210 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 166,30
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. xiii + 325.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, Springer Berlin Heidelberg, 2010
ISBN 10: 3642092284 ISBN 13: 9783642092282
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The emphasis on cancer management in the past was based primarily on control rates from multidisciplinary input in management. There has always been a recognition that one would like to achieve the best result with the least complication, but never has there been any major emphasis on evidence-based outcome studies, nor on functional preservation and quality of life. The authors of this book have dealt very effectively with the various tumor types in head and neck cancer with the experts in the eld of management. The contents range from epidemiology and treatment outcome, treatment techniques with the potential impact on the quality of life such as dysphagia, to the various options relative to high technology radiation therapy programs for mana- ment. The potential for improving form and function through surgical care as an integrated part of the program is dealt with very effectively as well as the potentials for chemotherapy and the use of targeted agents have on quality of life issues. The volume also addresses toxicity, quality of life, and techniques for prevention of adverse effects, as well as the potentials for rehabilitation and supportive care. The authors have clearly done an extraordinarily good job in addressing the mul- plicity of problems that impact upon the functional preservation and quality of life in head and neck radiation therapy. Philadelphia Luther W.
Da: Revaluation Books, Exeter, Regno Unito
EUR 175,01
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 338 pages. 11.00x8.27x0.81 inches. In Stock.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 122,12
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - from combining radiation with a molecular targeted agent - namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with loco-regionally advanced HNSCC in whom chemoradiation therapy is deemed not to be an option. While blocking the EGF pathway during fractionated radiotherapy may seem an obvious strategy [5], the rationale for combining antiangiogenic and antivascular targeting agents with radiation may be less intuitive. However, recent research shows that there are several reasons why this could result in a therapeutic gain in practice. Chapter 8 is a review of this rapidly expanding field by Citrin and Camphausen. Targeted agents combined with radiation may offer new opportunities in the treatment of central nervous system malignancies, a tumor type where the outlook remains poor despite some recent progress [6]. Current attempts to overcome rad- tion resistance in these tumors on the basis of an improved understanding of their molecular biology are the topic of Chap. 9 by Chakravarti and Palanichamy.
Da: Buchpark, Trebbin, Germania
EUR 83,50
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 352 | Sprache: Englisch | Produktart: Bücher | from combining radiation with a molecular targeted agent ¿ namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with loco-regionally advanced HNSCC in whom chemoradiation therapy is deemed not to be an option. While blocking the EGF pathway during fractionated radiotherapy may seem an obvious strategy [5], the rationale for combining antiangiogenic and antivascular targeting agents with radiation may be less intuitive. However, recent research shows that there are several reasons why this could result in a therapeutic gain in practice. Chapter 8 is a review of this rapidly expanding field by Citrin and Camphausen. Targeted agents combined with radiation may offer new opportunities in the treatment of central nervous system malignancies, a tumor type where the outlook remains poor despite some recent progress [6]. Current attempts to overcome rad- tion resistance in these tumors on the basis of an improved understanding of their molecular biology are the topic of Chap. 9 by Chakravarti and Palanichamy.
Da: Revaluation Books, Exeter, Regno Unito
EUR 182,74
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 360 pages. 9.00x6.00x0.83 inches. In Stock.
Lingua: Inglese
Editore: Springer Distribution Center GmbH (SDC), 2009
ISBN 10: 3540732314 ISBN 13: 9783540732310
Da: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italia
EUR 197,59
Quantità: 2 disponibili
Aggiungi al carrelloBrossura. Condizione: fine. Heidelberg, 2009; pp. 325. Libro.
Lingua: Inglese
Editore: Springer Distribution Center GmbH (SDC), 2007
ISBN 10: 0387367438 ISBN 13: 9780387367439
Da: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italia
EUR 197,59
Quantità: 1 disponibili
Aggiungi al carrelloBrossura. Condizione: fine. Heidelberg, 2007; pp. 341. Libro.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 200,35
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2009
ISBN 10: 3540732314 ISBN 13: 9783540732310
Da: moluna, Greven, Germania
EUR 178,14
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. With contributions by numerous experts|Is unique in focusing specifically on functional preservation and quality of life in patients with head and neck cancer treated by radiotherapy The use of short chapters and key point tables enables bu.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 325 1st Edition.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 168,73
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - from combining radiation with a molecular targeted agent - namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with loco-regionally advanced HNSCC in whom chemoradiation therapy is deemed not to be an option. While blocking the EGF pathway during fractionated radiotherapy may seem an obvious strategy [5], the rationale for combining antiangiogenic and antivascular targeting agents with radiation may be less intuitive. However, recent research shows that there are several reasons why this could result in a therapeutic gain in practice. Chapter 8 is a review of this rapidly expanding field by Citrin and Camphausen. Targeted agents combined with radiation may offer new opportunities in the treatment of central nervous system malignancies, a tumor type where the outlook remains poor despite some recent progress [6]. Current attempts to overcome rad- tion resistance in these tumors on the basis of an improved understanding of their molecular biology are the topic of Chap. 9 by Chakravarti and Palanichamy.
Lingua: Inglese
Editore: Springer, Berlin, Springer, 2009
ISBN 10: 3540732314 ISBN 13: 9783540732310
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 170,64
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The emphasis on cancer management in the past was based primarily on control rates from multidisciplinary input in management. There has always been a recognition that one would like to achieve the best result with the least complication, but never has there been any major emphasis on evidence-based outcome studies, nor on functional preservation and quality of life. The authors of this book have dealt very effectively with the various tumor types in head and neck cancer with the experts in the eld of management. The contents range from epidemiology and treatment outcome, treatment techniques with the potential impact on the quality of life such as dysphagia, to the various options relative to high technology radiation therapy programs for mana- ment. The potential for improving form and function through surgical care as an integrated part of the program is dealt with very effectively as well as the potentials for chemotherapy and the use of targeted agents have on quality of life issues. The volume also addresses toxicity, quality of life, and techniques for prevention of adverse effects, as well as the potentials for rehabilitation and supportive care. The authors have clearly done an extraordinarily good job in addressing the mul- plicity of problems that impact upon the functional preservation and quality of life in head and neck radiation therapy. Philadelphia Luther W.
Da: Revaluation Books, Exeter, Regno Unito
EUR 238,25
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 341 pages. 9.25x6.25x0.75 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 240,69
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 325 pages. 10.71x7.87x0.71 inches. In Stock.
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 298,46
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.